Invega (paliperidone) as a new atypical antipsychotic for schizophrenia
May 2007
You'll hear about Invega (paliperidone) as a new atypical antipsychotic for schizophrenia.
Health Canada is reviewing it now.
But the ingredient in Invega is not really that new...it's the active metabolite of risperidone (Risperdal).
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote